Skip to main content

2025 Milliman Life Sciences Policy Summit

In this time of legislative and regulatory uncertainty, Milliman is bringing together thought leaders and industry experts to discuss current and potential policy changes facing payers, providers, and the life sciences industry.

Life sciences image

Measure what matters

Milliman’s precise analytics and health policy expertise empowers our clients to make decisions with confidence.

Milliman has vast and varied expertise in quantifying and demystifying impacts of policy changes facing payers, providers, and life sciences organizations. In this time of legislative uncertainty Milliman’s data analytics and insights support strategic recommendations to best prepare for current and future regulatory changes.

Insight

Highlights from our latest research

Webinar

FDA in flux: Leadership, policy, and the road ahead

This webinar will provide an overview of how these dynamics—along with Congressional oversight, budgetary restrictions, and policy function mergers—are affecting the agency’s operations and strategic direction.

Watch the videoNavigation Arrow
White paper

Medicare price negotiation: Year 2 selection expands to new therapeutic areas

Insights from the list of negotiation-eligible drugs in 2027

Read the articleNavigation Arrow
workers collaborating at laptop
Article

5 ways actuaries support life sciences companies

By partnering with actuaries, life sciences companies can gain valuable insights into stakeholder strategies to best position their products for success.

Read the articleNavigation Arrow
Article

Most-Favored-Nation (MFN) Executive Order (EO): Six considerations for life science companies

After Trump’s executive order calling for most-favored-nation pricing for prescription drugs, we highlight six considerations for life science companies.

Read the articleNavigation Arrow
man looking out window
Article

3 reasons life sciences companies need strategies for engaging with ACOs

Value-based care (VBC) arrangements between providers and payers are continuing to grow, both in terms of contract volume and the number of lives these contracts cover.

Read the articleNavigation Arrow
Resource Card Placeholder
Interview

Life Sciences Insights with Katie Holcomb

How will the Inflation Reduction Act raise health plan costs—and how will plans, beneficiaries, and manufacturers respond?

Watch the videoNavigation Arrow

Event Moderators

Pamela Pelizzari headshot

Pamela M. Pelizzari

Principal
Pamela Pelizzari is a principal with the New York office of Milliman. She joined the firm in 2014.
View bioNavigation Arrow
Maggie Alston headshot

Maggie Alston

Principal
Maggie Alston is a principal based in New York. She joined Milliman in 2015.
View bioNavigation Arrow
Jeff Garbe headshot

Jeff Garbe

Senior Pharmacy Management Consultant
Jeff Garbe is a pharmacist and a senior pharmacy management consultant with the Milwaukee office of Milliman. He joined the firm in 2022.
View bioNavigation Arrow
Panel One

From complexity to clarity

Decoding the latest federal legislative and regulatory changes

Jake Klaisner headshot

Jake K. Klaisner

Principal and Consulting Actuary
Jake Klaisner is a principal and consulting actuary with the Milwaukee office of Milliman. He joined the firm in 2013.
View bioNavigation Arrow
Dan Simenc headshot

Dan Simenc

Principal and Consulting Actuary
Dan Simenc is a principal and consulting actuary with the Milliman Tampa office. He joined the firm in February 2012.
View bioNavigation Arrow
Rebecca Smith headshot

Rebecca Smith

Principal and Senior Healthcare Consultant
Rebecca Smith is a principal with the New York and Washington, DC, offices of Milliman. She joined the firm in 2020.
View bioNavigation Arrow
Andrew Badaracco

Andrew Badaracco

Senior Healthcare Policy Consultant
View bioNavigation Arrow
Panel Two

Charting the road ahead

Anticipating policy shifts and strategic responses

AJ Ally headshot

AJ Ally

Principal and Pharmacy Management Consultant
AJ Ally is a principal and pharmacy management consultant with the Chicago office of Milliman. He joined the firm in 2019.
View bioNavigation Arrow
Matthew Hayes headshot

Matthew Hayes

Principal and Consulting Actuary
Matthew Hayes is a consulting actuary in the Tampa office of Milliman. He joined the firm in 2016.
View bioNavigation Arrow
Massey Whorley headshot

Massey Whorley

Senior Healthcare Consultant
Massey Whorley is a senior healthcare consultant within the New York-Atlanta Health Practice. He joined Milliman to expand the healthcare policy service offerings by leveraging the company's actuarial and analytic strengths.
View bioNavigation Arrow

At Milliman, we recognize the transformative impact that federal policy changes have on the life sciences industry. Our work supports companies in navigating complex regulatory environments, leveraging data-driven insights, and developing strategic responses to changes.

We hosted the Life Sciences Policy Summit to provide a platform for experts in patient advocacy, market access, and healthcare policy to discuss the evolving federal landscape and potential outcomes, fostering dynamic conversations and valuable takeaways. We look forward to building on this foundation through further collaboration with life sciences companies and other key stakeholders.

We're here to help

Ask the tough questions. We're ready for them.